Identifying Potential p53‐MDM2 Interaction Antagonists: An Integrated Approach of Pharmacophore‐Based Virtual Screening, Interaction Fingerprinting, MD Simulation and DFT Studies-Reference-Cited by-同舟云学术

Identifying Potential p53‐MDM2 Interaction Antagonists: An Integrated Approach of Pharmacophore‐Based Virtual Screening, Interaction Fingerprinting, MD Simulation and DFT Studies

Published:2022-10-19 Issue:39 Volume:7 Page:
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Sedzro Divine Mensah¹²,Idris Mukhtar Oluwaseun²^ORCID,Durojaye Olanrewaju Ayodeji¹²³⁴^ORCID,Yekeen Abeeb Abiodun²^ORCID,Fadahunsi Adeola Abraham⁵⁶⁷,Alakanse Suleiman Oluwaseun²⁸

Affiliation:

1. MOE Key Laboratory of Membraneless Organelle and Cellular Dynamics Hefei National Laboratory for Physical Sciences at the Microscale University of Science and Technology of China Hefei Anhui 230027 China

2. School of Life Sciences University of Science and Technology of China Hefei Anhui 230027 China

3. Department of Chemical Sciences Coal City University, Emene Enugu State Nigeria

4. ACAII BIOHEALTH LTD, Ikotun Lagos State Nigeria

5. Graduate School of Biomedical Engineering (GSBSE) University of Maine Orono ME 04469 USA

6. Department of Oncology the First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui 230027 China

7. School of Information Science and Technology University of Science and Technology of China Hefei Anhui 230027 China

8. Department of Biochemistry Faculty of Life Sciences University of Ilorin Ilorin Kwara State Nigeria

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.202202380

Reference76 articles.

1. p53 mutations in cancer

2. Unravelling mechanisms of p53-mediated tumour suppression

3. Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin

4. Live or let die: the cell's response to p53

5. p53: Its Mutations and Their Impact on Transcription

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSC01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach;Amino Acids;2023-07-27

2. CHAPERONg: A tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses;2023-07-02

3. MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference;Scientific Reports;2023-04-28

4. CHAPERONg: A tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses;Computational and Structural Biotechnology Journal;2023